Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-129622
Filing Date
2024-12-18
Accepted
2024-12-18 08:05:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 15429
  Complete submission text file 0001104659-24-129622.txt   17261
Mailing Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302
Business Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302 201 985 8300
YA II PN, Ltd. (Filed by) CIK: 0001463928 (see all company filings)

EIN.: 980615492 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Subject) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91842 | Film No.: 241557631
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)